n(1)-methylnicotinamide has been researched along with Liver Steatosis in 1 studies
N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lai, S | 1 |
| Ma, Y | 1 |
| Hao, L | 1 |
| Ding, Q | 1 |
| Chang, K | 1 |
| Zhuge, H | 1 |
| Qiu, J | 1 |
| Xu, T | 1 |
| Dou, X | 1 |
| Li, S | 1 |
1 other study available for n(1)-methylnicotinamide and Liver Steatosis
| Article | Year |
|---|---|
1-Methylnicotinamide promotes hepatic steatosis in mice: A potential mechanism in chronic alcohol-induced fatty liver disease.
Topics: Animals; Chronic Disease; Ethanol; Fatty Liver; Fatty Liver, Alcoholic; Mice; Mice, Inbred C57BL; St | 2023 |